AKEBIA THERAPEUTICS, INC.
Profit Margins
| Period | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| Jun 2017 | — | -77.6% | -75.4% |
| Sep 2017 | — | -58.6% | -56.0% |
| Mar 2018 | — | -53.3% | -51.0% |
| Jun 2018 | — | -73.1% | -69.8% |
| Sep 2018 | — | -52.4% | -49.0% |
| Dec 2018 | 87.0% | -150.6% | -100.3% |
| Mar 2019 | 57.0% | -104.5% | -99.7% |
| Jun 2019 | 62.6% | -59.0% | -57.7% |
| Sep 2019 | 58.4% | -60.8% | -59.3% |
| Dec 2019 | 45.2% | -136.4% | -135.8% |
| Mar 2020 | 68.7% | -66.8% | -68.7% |
| Jun 2020 | -93.7% | -192.8% | -195.0% |
| Sep 2020 | 49.4% | -96.8% | -100.0% |
| Dec 2020 | -12.8% | -152.4% | -155.3% |
| Mar 2021 | 33.8% | -124.2% | -133.0% |
| Jun 2021 | 0.8% | -149.9% | -156.9% |
| Sep 2021 | 67.3% | -112.6% | -122.1% |
| Dec 2021 | 17.4% | -113.3% | -121.1% |
| Mar 2022 | 49.2% | -96.6% | -102.9% |
| Jun 2022 | 85.3% | 27.0% | 23.3% |
| Sep 2022 | 21.4% | -103.5% | -111.0% |
| Dec 2022 | 104.8% | -8.7% | -10.9% |
| Mar 2023 | 49.5% | -64.0% | -67.2% |
| Jun 2023 | 69.3% | -16.0% | -19.8% |
| Sep 2023 | 57.2% | -31.0% | -34.5% |
| Dec 2023 | 66.8% | 2.4% | 1.1% |
| Mar 2024 | 64.4% | -45.8% | -55.2% |
| Jun 2024 | 60.9% | -20.0% | -19.7% |
| Sep 2024 | 62.2% | -33.4% | -53.5% |
| Dec 2024 | 56.2% | -30.8% | -49.0% |
| Mar 2025 | 86.7% | 23.6% | 10.7% |
| Jun 2025 | 84.1% | 22.6% | 0.4% |
| Sep 2025 | 84.0% | 7.6% | 0.9% |
| Dec 2025 | 78.2% | -14.8% | -21.2% |
| Mar 2026 | 77.0% | -8.8% | -16.9% |
| Jun 2026 | 78.8% | -12.9% | -18.1% |